A pilot study in hemodialysis of an electrophysiological tool to measure sudden cardiac death risk

Clinical Nephrology

Volumn 68, Issue 3, 2007, Pages 159-164

  Friedman, A N ^a,b   Groh, W J ^a   Das, M ^a  

^a INDIANA UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Arrhythmia; Dialysis; Sudden cardiac death; T wave alternans

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; FEMALE; HEART FUNCTION TEST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEMODIALYSIS; HUMAN; HYPOTHESIS; MALE; NON INVASIVE PROCEDURE; PILOT STUDY; SUDDEN DEATH; T WAVE AMPLITUDE;

EID: 34548498424     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp68159     Document Type: Article

References (23)

1. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int. 1999; 55: 1553-1559.
2. Bleyer AJ, Hartman J, Brannon P, Reeves-Daniel A, Satko S, Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int. 2006; 69: 2268-2273.
3. Bloomfield DM, Hohnloser SH, Cohen RJ. Interpretation and classification of microvolt T wave alternans tests (see comment). J Cardiovasc Electrophysiol. 2002a; 13: 502-512.
4. Bloomfield DM, Ritvo BS, Parides MK, Kim MH. The immediate reproducibility of T wave alternans during bicycle exercise. Pacing Clin Electrophysiol. 2002b; 25: 1185-1191.
5. Chow T, Kereiakes D, Bartone C et al. Prognostic utility of microvolt T wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2006; 47: 1820-1827.
6. Cupisti A, Galetta F, Caprioli R et al. Potassium removal increases the QTc interval dispersion during hemodialysis. Nephron. 1999; 82: 122-126.
7. Fox JJ, McHarg JL, Gilmour RF Jr. Ionic mechanism of electrical alternans. Am J Physiol Heart Circ Physiol. 2002; 282: H516-530.
8. Herzog CA. Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist. Semin Nephrol. 2005; 25: 363-366.
9. Hohnloser SH, Klingenheben T, Li YG et al. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol. 1998; 9: 1258-1268.
10. Hohnloser SH, Ikeda T, Bloomfield DM et al. T wave alternans-negative coronary patients with low ejection and benefit from defibrillator implantation (see comment). Lancet. 2003; 362: 125-126.
11. Klingenheben T, Gronefeld G, Li YG, Hohnloser SH. Effect of metoprolol and d,l-sotalol on microvolt-level T wave alternans. Results of a prospective, double-blind, randomized study. J Am Coll Cardiol. 2001; 38: 2013-2019.
12. Lewis T. Notes upon alternation of the heart. Q J Med. 1910; 4: 141-144.
13. Luomanmalaki K, Heikkila J, Hartikainen M. T wave alternans associated with heart failure and hypomagnesemia in alcoholic cardiomyopathy. Eur J Cardiol. 1975; 3: 167-170.
14. Navarro-Lopez F, Cinca J, Sanz G, Magrina J, Betriu A. Isolated T wave alternans elicited by hypocalcemia in dogs. J Electrocardiol. 1978; 11: 103-108.
15. Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS. Mechanism linking T wave alternans to the genesis of cardiac fibrillation. Circulation 1999; 99: 1385-1394.
16. Pruvot EJ, Katra RP, Rosenbaum DS, Laurita KR. Role of calcium cycling versus restitution in the mechanism of repolarization alternans. Circulation Res. 2004; 94: 1083-1090.
17. Rosenbaum DS, Jackson LE, Smith JM et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med. 1994; 330: 235-241.
18. Strasser DM, Biblo LA, Smith JK et al. Is T wave alternans caused by left ventricular hypertrophy? PACE. 1997 abstract: 691.
19. Turitto G, Mirandi AP, Pedalino RP, Urelsky S, El-Sherif N. Short-term reproducibility of T wave alternans measurement. J Cardiovasc Electrophysiol. 2002; 13: 641-644.
20. US Renal Data System, USRDS 2004 Annual Data Report. Atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004. p. 168-173.
21. US Renal Data System, USRDS 2005 Annual Data Report. Atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2005. p. 125.
22. Verrier RL, Nearing BD. Electrophysiologic basis for T wave alternans as an index of vulnerability to ventricular fibrillation. J Cardiovasc Electrophysiol. 1994; 5: 445-461.
23. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with Type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005; 353: 238-248.